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Abstract Effect-directed analysis has been applied to a
river sediment sample of concern to identify the compounds
responsible for the observed effects in an in vitro (anti-)
androgenicity assay. For identification after non-target
analysis performed on a high-resolution LTQ-Orbitrap, we
developed a de novo identification strategy including
physico-chemical parameters derived from the effect-
directed analysis approach. With this identification strategy,
we were able to handle the immense amount of data
produced by non-target accurate mass analysis. The effect-
directed analysis approach, together with the identification
strategy, led to the successful identification of eight
androgen-disrupting compounds belonging to very diverse
compound classes: an oxygenated polyaromatic hydrocar-
bon, organophosphates, musks, and steroids. This is one of
the first studies in the field of environmental analysis
dealing with the difficult task of handling the large amount
of data produced from non-target analysis. The combination
of bioassay activity assessment, accurate mass measure-
ment, and the identification and confirmation strategy is a
promising approach for future identification of environ-
mental key toxicants that are not included as priority
pollutants in monitoring programs.
Keywords LTQ-Orbitrap . Non-target analysis .
Identification . (Anti-)androgenic . Effect-directed analysis
(EDA) .MODELKEY
Introduction
In the year 2000, the Water Framework Directive (WFD)
stated a demand for a good ecological status of European
surface waters by 2015. A key issue is to identify the most
important active compounds causing a specific effect, i.e., the
key toxicants, in the aquatic environment. One of the
approaches used to trace key toxicants is the application of
effect-directed identification for the establishment of cause–
effect relationships. Effect-directed analysis (EDA) studies
employ bioassay-directed fractionation techniques to decrease
the complexity of the sample matrix before identification of
the active compounds. This fractionation approach is a non-
selective and non-destructive clean-up methodology that aims
to enable the identification of all biologically active com-
pounds in the sample. EDA has successfully been applied to
evaluate endocrine potencies in several water systems, such as
waste-water treatment plants [1, 2], rivers [2, 3], harbor areas
[4], marine sediment [5], and biota [6].
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The identification of key toxicants and the final
confirmation of toxicity and identity are critical for the
success of EDA studies. In the past few years, this aspect of
EDA has been lacking due to the immense number of
compounds present in the complex samples, even after
extensive fractionation. A common approach is target
analysis of certain compound groups, based on prior
structure-toxicity knowledge [5, 7, 8]. This excludes the
possibility to identify compounds with unknown modes of
action, or the identification of emerging pollutants. The
amounts and purity of the compounds present are often not
sufficient for spectrometric analysis using nuclear magnetic
resonance spectroscopy or infrared spectroscopy, and thus,
more theoretical methods need to be employed in the
process, e.g., using classifiers, structural alerts, or even
database-screening to limit the number of compounds to be
handled [9–11]. Traditionally, in the area of environmental
analysis, gas chromatography coupled to mass spectrometry
(GC/MS) has been applied extensively. We used GC/MS
for the identification of compounds causing the observed
androgenic activity in an EDA study in sediment from the
river Scheldt basin in Belgium, at the location Schijn
Eenhoorn. The sample extraction, cleanup, and fraction-
ation strategy as well as the bioassay results have been
described in detail, and the GC/MS results of the tentatively
identified compounds are discussed elsewhere [12].
Complementary to that study, a parallel analytical
strategy using liquid chromatography coupled to mass
spectrometry (LC/MS) was developed to identify the more
polar and less volatile compounds, which might be over-
looked when using GC/MS techniques. Although LC/MS is
the method of choice for the analysis of more polar
compounds, there is a lack of accessible, easy-to-use
spectral libraries or databases for compound identification,
in analogy to those available for GC/MS identification (e.g.,
the NIST library). This demands the development of
alternative approaches for structure elucidation exploiting
as much information as possible gained from parameters
such as chromatographic retention, physical–chemical
properties, spectral data, etc.
To enable the identification of unknown compounds by
LC/MS techniques, the use of equipment that is capable of
accurate mass measurements, e.g., the LTQ-Orbitrap, is a
prerequisite. At present, there is a wide range of software
for processing LC/MS mass scans, from the commercially
available Mass Frontier (Thermo Fisher Scientific) and
ACD/MS fragmenter (ACD/labs) to freely available
MZmine [13], XCMS [14], and FiD [15]. In this study,
we used SIEVE software (Thermo Fisher Scientific) to
facilitate the identification process of unknown compounds.
SIEVE is designed to enable users to analyze large amounts
of data generated with LC/MS techniques, especially within
the field of –omics, such as metabolomics [16] and
proteomics [17]. Our aim was to develop and implement
an integrated strategy for the identification of key toxicants
using accurate mass LC/MS. Our approach was demon-
strated for a sediment extract by the identification of
unknown compounds that are responsible for the observed
androgenic and anti-androgenic effects in an EDA study in
the river Scheldt basin.
Materials and methods
The sample and the EDA methodology have been described in
detail earlier [12]. In short, it included accelerated solvent
extraction, gel permeation chromatography (GPC), reversed
and normal phase (RP and NP) liquid chromatography (LC)
techniques. Androgenic activity was determined in the AR-
CALUX® bioassay [18]. Dihydrotestosterone (DHT) was
used as a reference androgen receptor (AR) agonist. Antag-
onism (−AR) towards the AR was also determined by testing
the extracts in combination with the EC50 of DHT (200 pM).
Flutamide (FLU) was used as the reference antagonist. The
GPC fraction (whole extract) and all five RP fractions (based
on increasing octanol–water coefficient [Kow]) were tested in
the bioassays. The RP fractions which were active in the
bioassays were selected for further fractionation on an NP
column, separating the compounds according to their polarity.
Chemical analysis with the LTQ-Orbitrap
The fractions were analyzed on an Xbridge C18-LC column
(Waters, 100×2.1 mm 3.5 ìm) connected to a linear
quadrupole ion trap—Orbitrap (LTQ-Orbitrap) mass spec-
trometer (Thermo Electron) equipped with an electro-spray
ionization source (ESI). The eluent flow rate was 0.2 mL/
min, and the solvent gradient used was 5% to 95% MeOH
(solvent A, 5% MeOH/95% MilliQ water+0.05% formic
acid; solvent B, 95% MeOH/5% MilliQ water+0.05%
formic acid) in 25 min. The mass spectrometer was
operated in the positive ionization mode (the negative
ionization mode was evaluated but not reported). The data-
dependent mode was activated to automatically switch
between Orbitrap-FTMS and LTQ-MS/MS data acquisition
(MS2 and MS3 data were not used, but the information is
saved for eventual future investigations). Survey full-scan
MS spectra (from m/z 50 to 600) were acquired in the
Orbitrap with a resolution of 30,000.
Identification strategy
The identification strategy is described in Table 1, including
aspects of each step that will be addressed in the Results
and discussion section. The software SIEVE (Thermo
Fisher) was used to sieve the active (observed (anti-)
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androgenic activity) and the non-active fractions (no
observed (anti-)androgenic activity) to discriminate the
peaks of interest. SIEVE identifies statistically significant
changes in relative signal intensity of m/z values in a
predefined experimental design, which typically is a two-
group randomized controlled study. SIEVE operates in two
steps, a first alignment of the chromatogram employing a
ChromalignTM algorithm and, secondly, a recursive base-
peak framing. The end product is a list of accurate masses
(peaks) and the ratio of the peak intensity between sample
and control and the p value of the significant difference.
Settings during the sieving procedure were a threshold of
500,000 which determines the lowest mass intensity that
triggers framing: window of m/z 150–600; 1 min frame
time window; 0.02 frame m/z width; retention time 9–
17 min; and 30% peak width. The basic requirement to
select m/z values of interest was that the difference was
significant (p value<0.05). Secondly, a threshold was set to
include only peaks with a ratio of >100 between peak
intensity in active and non-active EDA fractions. The peaks
with a lower intensity ratio may also be of interest, but
these were not addressed in this project to limit the data set
volume. A third requirement was that the suggested
chemical formulas extracted from the accurate mass (via
the elemental composition tool in Xcalibur, Thermo Fisher)
should be present in the NIST spectral database and
optimally be attributed a CAS number to simplify the
purchase of the compounds for further confirmation studies.
To cross-check whether major errors in the identification
of unknown toxicants have been made using our identifi-
cation strategy based on the NIST database, PubChem was
selected as the most suitable alternative for the purpose of
our study: the identification of unknown pollutants through
a combination of biological and chemical characteristics
that we have obtained through EDA. PubChem is an
example of a shared database that collates an immense
amount of data from various existing databases. The focus
of PubChem is on biological activity and on compounds
that chemically resemble bioactive compounds. The chem-
ical formulas determined in the three most potent fractions
(RP3NP2, RP3NP5, and RP3NP6) were searched in
PubChem, and results were compared with those obtained
searching the NIST library.
Each tentatively identified compound’s inherent Kow was
correlated to the Kow of the fraction in which it was found
(the log Kow range for the RP fractions 1–5 are <2, 2–4, 4–6,
6–9, and >9, ±0.5 [12]). The logarithmic Kow values were
calculated with EPI Suite (KOWWIN v1.67, U.S. EPA) and
are hence theoretical values.
Quality assurance/quality control
Analytical The instrumental mass tolerance was between
0.3 and 3 ppm (Table 2), and the typical setting was 2 ppm
for the identification of m/z values in Xcalibur. The
purchased compounds, indicated in Table 2 and the
Table 1 The description of the identification strategy of the active compounds present in the fractions, with the software used (method) and the
limitations of each step
Workflow Method Limitations
1. LTQ-Orbitrap analysis of EDA identified fractions
(sample=active fraction, control=non-active
fraction)
LTQ-Orbitrap/Xcalibur Electron spray ionization is a soft ionization technique
and could hence exclude many compounds, matrix ion
suppression
2. SIEVE procedure, aligns and base-peak frames the
masses
SIEVE No true control samples
3. Excel sheet with extracted information (peak nr, ratio
between control and sample, accurate mass and
retention time)
Excel Ratio >100 between peak intensity in active and non-
active fraction. Ratio <100 not tested.
4. Manual check of the peak quality (peak shape, isotopes
to the molecular ion, base line elevation, etc.
Xcalibur Time-consuming
5. Generate the chemical formula from the m/z in the
elemental composition tool in Xcalibur
Xcalibur elemental
composition tool
Selected elements: N, O, C, H, F, Cl, Br, I, Si. P, S
6. NIST search of the suggested chemical formula
(Observed m/z is [M+H] + and hence one hydrogen
needs to be deleted in the search)
NIST Limited representation of polar compounds and other
less known products
7. Generate the log Kow , and match with the expected
log Kow of the active fraction.
EPI Suite Theoretical values
8. Purchase and confirm analytically by retention time LTQ-Orbitrap/Xcalibur Lack of available standards
9. Confirm the activity in the corresponding bioassay Bioassay Lack of available standards
10. List of identified and confirmed active compounds to
be target analyzed for concentration determination to
determine the contribution to the overall activity of
the sample.
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Electronic Supplementary Material Table S1, were ana-
lytically confirmed by retention time (±0.02 s). The
instrumental limit of detection (LOD) was set as a
minimum peak height of 50,000 relative response units
due to bad peak shape below that threshold. The LODs
ranged from <20 μg/L up to 630 μg/L (10-μL injection),
depending on the ionization efficiency of the identified
compound (Table 2). A solvent blank sample (extracted
clean sand) was analyzed in parallel to measure back-
ground contamination. No bioassay activity was detected
in any solvent blank fractions.
SIEVE The performance of the SIEVE program was
evaluated with respect to the chromatogram alignment and
base-peak framing procedure. The identified compounds
(n=8) were added to a non-active sediment extract at four
concentration levels (0.1–5.0 mg/L) and analyzed on the
LTQ-Orbitrap. The obtained data were evaluated using
SIEVE. Of the eight compounds, seven were peak-framed
successfully and reported a ratio >100 compared with the
control sample (non-spiked extract) at the lowest added
concentration (0.1 mg/L). The eighth compound was 5α-
androst-16-en-3-one (androstenone) which has a high LOD
(Table 2) due to ionization difficulties in ESI mode.
Detection of androstenone was not possible below a
concentration of 3 mg/L (SIEVE mass threshold setting
was 500,000 and mass intensities below that was not
selected for base-peak framing), suggesting that the
concentration in the active fraction in which this compound
was identified was rather high.
Apart from the eight parent compounds used for the
spiking experiment, 51 m/z values were selected with a
ratio >100 between spiked (at a level of 0.1 mg/L) and non-
spiked extract. In total, 24 of these m/z values were present
in the pure standard mixture added to the sample, while
6 m/z values were the isotopes of another mass ([M+H+1]+
or [M+H+2]+ ions). The identity of the remaining 14 m/z
values could not be explained, but the possibility that these
signals belong to adducts containing alkali metal ions and
solvent molecules should be taken into account.
Results and discussion
Bioassay results as starting point for identification
The bioassay results of the sediment sample from Schijn
Eenhoorn are given in Fig. 1, revealing the active and non-
active fractions. The sediment extract was first reversed
phase (RP) fractionated separating compounds according to
their log Kow value and secondly with normal phase (NP)
LC giving fractions with increasing polarity. In total, three
distinct clusters of active fractions could be observed. There
were two potent anti-androgenic clusters consisting of one
non-polar group (RP3NP2 and RP4NP2) and one slightly
more polar group (RP3NP5 and RP3NP6), and one cluster
of polar androgenic compounds (RP3NP7 and RP4NP7).
The bioassay results are discussed in detail elsewhere [12].
Identification strategy
The data handling strategy represented in Table 1 consists
of ten steps (described in detail below) to be performed in
order to obtain a list of identified and confirmed biologi-
cally active compounds in the sample of interest. The
method is not complicated, but since it incorporates several
different software programs, it is laborious and time-
consuming. Automatic data processing could drastically
decrease the work load. However, in this study, there was
no possibility to investigate the compatibility of the used
Table 2 The name, CAS number, chemical formula, and the mass-to-
charge ratio (m/z) as measured in the LTQ-Orbitrap (assumed to be
[M + H]+) of the identified and confirmed compounds present in EDA
sediment, as well as the limit of detection (LOD, μg/L) and mass
tolerance (ppm) established in the sample. Androgenic and anti-
androgenic potency are expressed as dihydrotestosterone (DHT) and
flutamide (FLU) equivalence factors (EF), respectively, for the AR-
CALUX® on a molar basis (Reference EC50/Compound EC50)
Compound CAS number Molecular
formula
[M + H]+
(m/z)
LOD (μg/L) Mass tolerance
(ppm)
DHT EF FLU EF
7 H-Benz[de]anthracen-7-one 82-05-3 C17H10O 231.0806 20 0.9 1.4E-02
Galoxolide 1222-05-5 C18H26O 259.2058 20 0.8 3.9E-01
Tonalide 1506-02-1 C18H26O 259.2058 <20 1.2 3.2E-01
Traseolide 68140-48-7 C18H26O 259.2058 <20 0.8 2.2E-01
Tris-(2-chloroisopropyl)
phosphate
13674-84-5 C9H18Cl3O4P 327.0082 <20 0.3 2.0E-04
Tris-(2-ethylhexyl) phosphate 78-42-2 C24H51O4P 435.3591 <20 3.0 1.7E-02
Nandrolone 434-22-0 C18H26O2 275.2004 <20 0.7 1.2E-01
5α-Androst-16-en-3-one 18339-16-7 C19H28O 273.2215 630 2.2 1.0E-15 7.7E+00
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software programs. In Table 3, the results of the various
steps in the procedure are given, represented by numbers of
peaks remaining after a specific step.
The first step in Table 1 is the analysis of the fractions on
the LTQ-Orbitrap to obtain accurate mass measurements of
the compounds present in the fractions. The soft ionization
technique (ESI) used to create molecular ions may not be
optimal for all compound groups. Therefore, one should
realize that the choice of LC/MS interface inherently
influences the identification results. In general, the choice
for a specific analytical technique for identification of
unknowns inevitably narrows the scope of the results that
can be obtained. All fractions were analyzed both in
positive and negative ionization mode, but since the m/z
signals in the negative ionization mode did not contribute to
the results list, the data are not presented here.
The second step involves the SIEVE program, used to
align and frame the mass chromatographic peaks that
should be evaluated for identification. A comparison with
a control sample is part of this procedure. In EDA studies,
the fractions that show activity in the bioassay are the
fractions of interest in which the active compounds need to
be identified. In our study design, we used two control
samples for the SIEVE procedure. The first control is the
non-active fraction adjacent (on the RP fractionation axis or
the NP fractionation axis) to the active fraction, while the
second is the identical fraction of a solvent blank sample.
One limitation in our application is that SIEVE is designed
for controlled studies, with exposure (sample) and non-
exposure (control) scenarios in the same matrix. In the
current study design, there is no “true” control sample: a
“true” control would be the same fraction as the active
fraction in the fractionation scheme presented (Fig. 1),
originating from a sample with no activity from an identical
environment, i.e., containing all the non-active compounds.
However, such a control sample/extract was obviously not
feasible.
In the third step, a ratio of >100 of the mass intensities
between active fraction and control fractions, was adopted
as a threshold. The lack of true control samples led to the
Table 3 The number of m/z values discriminated in the active
androgenic fractions (agonistic or antagonistic and corresponding
reversed phase [RP] and normal phase [NP] fractions) corresponding
to identifications steps 1–10, separated into: the number of base-peak-
framed m/z values from SIEVE; the number of m/z values with a ratio
between 10–100 and >100 between control and sample; tentatively
identified compound (some m/z values have multiple possibilities);
available compounds for the confirmation steps; the analytically
confirmed and the bioassay-confirmed compounds that represent the
key toxicants in the sample
Bioassay
activity
Fraction SIEVE m/z
values
Ratio >100 m/z
values
Tentatively
identified
Available
compounds
Analytical
confirmed
Bioassay-
confirmed
Identification step 2 3–4 7 8 8 9
Agonistic RP2NP7 1,002 38 25 8 2 1
RP3NP7 2,915 62 7 1 0 0
Antagonistic RP2NP6 1,206 35 6 2 1 1
RP3NP2 3,309 26 2 0 0 0
RP3NP5 1,141 42 42 7 5 4
RP3NP6 2,940 26 4 2 1 1
RP4NP2 291 1 1 0 0 0
RP4NP7 2,003 29 8 2 1 1
Total 14,807 259 95 22 10 8
Androgenic activity (>1% induction)
Anti-androgenic activity indicated <LOQ (1-20%) 
RP5
RP4
RP3
RP2
RP1
NP8NP7NP6NP5NP4NP3NP2NP1
Anti-androgenic activity >LOQ (20% inhibition)
Fig. 1 Overview of bioassay
results integrating both
androgenic as well as
anti-androgenic activity from the
reversed phase (RP) and normal
phase (NP) fractions. Active
(filled) and non-active (empty)
fractions are indicated. These
bioassay results have been
reported in detail earlier [12]
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inclusion of a relatively large number of compounds that
were in fact not related to the observed biological activity.
Because of the labor-intensive identification strategy, there
was a need to reduce the amount of data, and therefore the
relatively arbitrary threshold of a ratio of >100 between
active and non-active fractions was implemented. The
reduction of data is illustrated in Table 3: after the
application of the SIEVE program, a number of signals in
the order of some ten thousands was obtained for most of
the active fractions, while after implementation of a
threshold of an intensity ratio of >100 between active
fractions and control fractions to a few 100 peaks remained
for all active fractions.
A general aspect of SIEVE is that the program is base-
peak framing m/z values with a reasonable peak shape,
although errors occurred where an elevated baseline could
be selected, or isotope masses [M+H+1]+ and [M+H+2]+
could be included if the intensity of the peak was enough
for selection. Although very time-consuming, it was
therefore necessary to check the peaks one by one after
selection, both the shape and the m/z values with the same
retention time (step 4).
In the Xcalibur, elemental composition tool (step 5) the
elements known to be present in environmental toxicants
were pre-selected, including nitrogen, oxygen, carbon,
hydrogen, fluorine, chlorine, bromine, iodine, silicon,
phosphorous, and sulfur. The tool calculates which elemen-
tal compositions would fit the accurate masses of the
unknown compounds determined by the Orbitrap. The
accurate mass is the principal parameter in our identifica-
tion pipeline. We have designed our strategy for protonated
molecular ions because these represent the most dominant
ions in the mass chromatograms, but there is a possibility
that we are dealing with solvent adducts or adducts
containing alkali metals such as Na+ and K+. This
phenomenon could lead to erroneous results in the
identification of unknown compounds [19].
In step 6, the suggested molecular formulas (minus one
[H]+) are checked for presence in the NIST spectral
database, that contains around 200,000 compounds and is
an electron impact and highly GC/MS-oriented database. In
addition, within the NIST database, there is a smaller LC/
MS library available (nist_msms) that contains ∼4,000
positive ion spectra), which was also used.
The last theoretical step (step 7) in filtering the
interesting compounds from the bulk of non-active com-
pounds was to check whether the compound’s Kow matched
with the Kow window of the RP fraction. The log Kow of all
candidates was determined with EPI Suite, which has been
reported to have a correlation coefficient (r2) of 0.94
between experimental and calculated values for log Kow’s.
A source of error could be the deviation of the Kow window
of the fractions (±0.5) [12]. In order to minimize such
errors, prior to each RP fractionation, a standard solution
(known RT and log Kow) was injected to the preparative LC
column to check the stability of the system. Still, the
presence of matrix could alter the elution and the RT of the
compounds on the column during fractionation.
After the first seven steps discussed above, the number
of m/z values has decreased from a total of 14,807 to 59
peaks of interest. Since some m/z values can consist of
isomers or have multiple possible identities, 95 possible
compounds are presented in the Table S1. In conclusion, of
the selected 259 m/z values of interest (ratio >100) 59 m/z
values were tentatively identified, i.e., 23%.
For confirmation purposes, only 22 of the tentatively
identified compounds could rapidly be purchased via major
providers. Half of the purchased compounds could be
analytically confirmed (by RT, step 8), but none of them
was present at such intensity that they were MS/MS-
fragmented for identification purposes. Finally, the activity
of eight of those compounds could be confirmed in the
bioassay (step 9).
When using the PubChem database instead of the NIST
library (in step 6) to search for compounds matching the
molecular formulas determined in the three selected, most
potent fractions (RP3NP2, RP3NP5, and RP3NP6), hardly
any significant new results were obtained. Quite unexpect-
edly, the search function in PubChem showed some
practical limitations when using it for identification
purposes. In fact, a number of compounds that we
identified through NIST searching that could be analytically
and biologically confirmed were not found via PubChem
searching at all. For mass spectral searching under the
umbrella of the PubChem database, only the NIST
Chemistry WebBook, which is a separate product from
the overarching NIST Spectral Libraries, is covered in
PubChem. The NIST Chemistry Webbook contains infor-
mation on less compounds than the NIST library itself,
thereby limiting the applicability identification of unknown
toxicants. However, one compound was exclusively found
in PubChem and added to the supplementary Table (S1).
Identified compounds
The identified and confirmed compounds described in
Table 2 are three polycyclic musks, two organophosphates,
two steroids, and one oxygenated polycyclic aromatic
compound. Three of them, galaxolide, androstenone, and
Tris-(2-chloroisopropyl) phosphate (TCPP), were estimated
to be present in a rather high concentration (>1 μg/g
sediment) based on peak intensity and detection limit. The
compounds androstenone and galaxolide exhibit strong
antagonistic AR binding potency in the AR-CALUX®,
having equivalent factor (EF) values of 7.7 and 0.39,
respectively. Androstenone is a steroidal pheromone found
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in both male and female sweat and urine. It is the active
ingredient in Boarmate™, a commercial product sold to pig
farmers to test sows for timing of artificial insemination
[20]. The simultaneous weak androgenic and strong anti-
androgenic potency in the AR-CALUX® observed for
androstenone could most probably be explained by partially
agonistic behavior, i.e., despite the activation of the AR
there is an additional, dominant pathway leading to anti-
androgenic activity [18]. The androstenone tested here was
only one suggested structure from nine (Table S1). It is
likely that other isomers are present in the active fraction.
The other compound exhibiting androgenic potency was
nandrolone (17β-19-nortestosterone), an anabolic steroid
naturally present in the human body. Nandrolone is
administered as an anabolic agent for fattening veal calves
and cattle, although the use of hormones for growth-
promotion or fattening is prohibited in the EU [21, 22]. The
retention time of the purchased nandrolone corresponded
to one low-intensity peak within an isomer cluster of the
accurate mass. It was not possible to confirm the
presence of other androgenic compounds (due to lack
of standards) in this study, but indications of several
steroids in the tentatively identified compounds list
(Table S1) suggest that natural and synthetic steroids are
candidates that may be partially responsible for the effects
found in the fractions.
Musks, such as the polycyclic musks identified here, are
widely used synthetic fragrances. They can be found in
almost all consumer products, e.g., perfumes, deodorants,
cosmetics, soaps, shampoos, laundry detergents, fabric
softeners, household cleaners, and air fresheners [23].
Polycyclic musks are highly lipophilic (log Kow ∼6) and
are well-known to be emitted into waste-water, reach
freshwater, and the marine environment and finally accu-
mulate in sediment, sludge, and biota [24, 25]. High
concentrations of galaxolide and tonalide have been
reported in sediment from the Berlin area (Germany) strongly
polluted with sewage sludge (median concentration of each
compound was 0.9 mg/kg dw), whereas non-contaminated
sediment contained levels below <0.02 mg/kg [26]. Schreurs
and coworkers have shown that galaxolide and tonalide are
exhibiting mainly anti-estrogenic activity in both in vitro and
in vivo assays (zebra fish) [27]. Both antagonistic ERβ and
AR antagonistic potency for galaxolide and tonalide (−AR
EF 0.25 and 0.20) have been described using the same AR-
CALUX® assay as reported here [28].
The oxy-polycyclic aromatic hydrocarbon (PAH) 7 H-benz
[de]anthracen-7-one (benzanthrone) is widely found in the
environment. An important source is its use as a dye
intermediate for the synthesis of vat and disperses dyes [29].
Benzanthrone is also detected in atmospheric aerosols and
combustion-related particulate emissions [30]. The mutagenic
and acute toxic properties of benzanthrone are well reported
due to the fact that it is an industrial chemical and tested in an
array of biological and toxicological assays [30]. Only one
study has reported benzanthrone levels in sediment from the
river Elbe basin at several locations. Benzanthrone was found
to be present in one sediment fraction with high algal toxicity
at a concentration of 1.2 μg/g dw [7].
Due to its increased use, the European Commission
published an updated risk assessment report on the
organophosphate tris-(2-chloroisopropyl) phosphate
(TCPP) [31]. Chlorinated alkylphosphate esters, particular-
ly TCPP, have been identified as possible substitutes for the
flame retardant pentabromodiphenyl. TCPP has been
detected as one of the most abundant compounds in
effluents of municipal waste-water treatment plants in
Austria and the TCPP levels from the surrounding river
sediments were reported to <LOD up to 1,300 ng/g dw
[32]. Several studies have shown that the wastewater
treatment plants are not able to sufficiently decrease the
TCPP levels of the effluent compared with influent [31,
33]. The identified and bioassay-confirmed organophos-
phates in this study, TCPP, and tris-(ethylhexyl) phosphate
are only exhibiting moderately anti-androgenic activity
(FLU EF 2E-04 and 1.7E-02). It is likely that other
compounds of this class are present in these fractions,
based on GC/MS data evaluation [12], where several peaks
indicated organophosphates.
Some of the tentatively identified compounds that were
not tested here could be suspected to cause androgenic
disturbances, such as steroids, pheromones, and fragrances
(Table S1), but no literature was found to confirm neither
the presence nor the activity of these compounds. Informa-
tion was searched via the search tool Google, and hits are
indicated in the Table S1 for each tentatively identified
compound.
The list of androgen-disrupting compounds identified in
this study, together with earlier identified (GC/MS) key
toxicants in the same fractions [12], consists of PAHs, oxy-
polycyclic aromatic hydrocarbon (PAH), nonylphenol iso-
mers, phthalates, organophosphates, musks, and steroids.
Interestingly, only a very limited number of compounds
were identified by both techniques, which shows that the
combination of GC- and LC-based identification techniques
is a powerful and complementary approach for the
identification of unknown compounds. Of the compounds
identified in the same fractions using these complementary
techniques, only PAHs and nonylphenol are on the WFD
priority list. One phthalate, dibutyl phthalate, is a candidate
substance for the priority pollutants list as well as musk
xylene, but not the polycyclic musks as identified here [34].
There is currently no regulation regarding the organo-
phosphates in the EU [31]. In the supplement data list
(Table S1), there are several candidates presented that may
be included in future investigations.
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Identification of unknowns: state-of-the-art, limitations,
and future aspects
The identification pipeline that we have developed is a
sequence of data treatment steps that aims at the reduction
of mass signals and results in a list of identified compounds
with biologically confirmed activity that is present in the
analyzed sediment sample. With regard to the difficulties
encountered in the identification of unknown compounds,
there is a striking analogy between the fields of EDA and
(environmental) metabolomics. Concepts already developed
for the identification of unknown compounds from metab-
olomic origin [19, 35] such as the filtering of molecular
formulas obtained by accurate mass spectrometry and
procedures for correct deduction of molecular formulas
from molecular ions that are not simply protonated parent
compounds, could possibly be applied for the improvement
of the de novo identification of unknown key toxicants.
In our strategy, several arbitrary thresholds, settings, and
assumptions have been included that, without any doubt, lead
to the exclusion of valuable information. In other words, we
have only studied the metaphorical tip of the iceberg.
However, in order to be able to mine the huge amount of
available data from non-target analysis and to identify the
most abundant key toxicants, these choices were unavoidable.
In order to become more widely applicable, the development
of an automated workflow instead of the time-consuming step
by step treatment of the data is an absolute requirement.
In our work, the use of the NIST database for the
identification of unknown compounds may to a greater or
lesser extent have biased the outcome of our studies. The
NIST database is originally compiled as a GC/MS database
and therefore intrinsically not fully suitable as a tool in the
de novo identification of environmental pollutants by LC/
MS. It seems inevitable that all databases are biased
towards a target research area or group(s) of compounds,
thereby automatically influencing the outcome of the
database searching. For a realistic and feasible, reliable
identification of unknown compounds, it is essential to
choose the database that includes the information that is
most relevant for the field of study or the application area.
Currently, there seems to be a common need in various
fields of research including genomics, metabolomics, and
environmental analysis for databases that can be consulted
for the identification of unknown compounds, varying from
DNA fragments to mammalian and environmental metab-
olites and lipids to environmental key toxicants [36, 37].
Although, apart from the NIST and PubChem, various
databases are available, e.g., MassBank and more biolog-
ically oriented databases such as KEGG and HMDB, there
is still an enormous need for development, improvement,
and streamlining of databases for the identification of
unknown compounds from various origins.
Here, we present an identification strategy of compounds
having an (anti-) androgenic effect using a non-target
analysis approach. The next step will be to perform target
analysis of the identified compounds to estimate whether
the compounds could qualitatively and quantitatively
explain the measured effects. This step also includes
mixture toxicity issues when adding up the identified
compounds in concentrations reflecting the environmental
exposure. Finally, the hazard confirmation addresses the
question whether the identified compounds pose a risk for
the ecosystem. Hazard confirmation takes parameters into
account that describe the exposure conditions in the field, e.
g., bioavailability, individual and organism differences, and
mixture effects. The hazard confirmation, going beyond the
analytical and effect confirmation, will result in a realistic
picture of the environmental exposure and is highly
relevant for risk assessments.
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